Book Text

REFERENCES

1. Williams CT: The compressed air bath and its uses in the treatment of disease. BMJ 1:769, 1885.

2. Corning JL: The use of compressed air to enhance and prolong the action of remedies upon the cerebrospinal axis: Synopsis of experiences in applying the method over six thousand times. Am Med 5:529, 1903.

3. Cunningham OJ: Oxygen therapy by means of compressed air. Anesth Analg 6:64, 1927.

4. American Medical Association Bureau of Investigation: The Cunningham "Tank Treatment." The alleged value of compressed air in the treatment of diabetes mellitus, pernicious anemia and carcinoma. JAMA 90:1494, 1928.

5. Fontaine J-A: Emploi chirurgical de l'air comprimé. Un Méd Paris 28(Sér 3):445, 1879.

6. Zuntz N: Zur Pathogenese und Therapie der durch rasche Luftdruckänderungen erzeugten Krankheiten. Fortschr Med 15:632, 1897.

7. Yarbrough OD, Behnke AR: The treatment of compressed air illness using oxygen. J Ind Hyg Toxicol 21:213, 1939.

8. Cochran WD, Levison H, Muirhead DM Jr, et al: A clinical trial of high oxygen pressure for the respiratory-distress syndrome. N Engl J Med 272:347, 1965.

9. Boerema I, Meijne NG, Vermeulen-Cranch DME: Observations during operation on deeply cyanotic young children breathing oxygen at three atmospheres absolute. Surgery 52:796, 1962.

10. Bernhard WF, Norman JC, Ishizuka R, Carr JG: Evaluation of hyperbaric surgery in infants with congenital cardiac defects. In Brown I, Cox B (eds): Proceedings of the Third International Conference on Hyperbaric Medicine. Washington, DC, National Academy of Sciences, 1966, p 345.

11. Feldmeier JJ: Hyperbaric Oxygen 2003. The Hyperbaric Oxygen Therapy Committee Report. Kensington, MD, Undersea and Hyperbaric Medical Society, 2003.

12. Moon RE, Gorman DF: Treatment of the decompression disorders. In Bennett PB, Elliott DH (eds): The Physiology and Medicine of Diving. Philadelphia, WB Saunders, 1993, p 506.

13. Moon RE, Sheffield PJ: Guidelines for treatment of decompression illness. Aviat Space Environ Med 68:234, 1997.

14. Leitch DR, Green RD: Pulmonary barotrauma in divers and the treatment of cerebral arterial gas embolism. Aviat Space Environ Med 57:931, 1986.

15. Thom S, Taber R, Mendiguren I, et al: Delayed neuropsychologic sequelae after carbon monoxide poisoning: Prevention by treatment with hyperbaric oxygen. Ann Emerg Med 25:474, 1995.

16. Weaver LK, Hopkins RO, Chan KJ, et al: Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347:1057, 2002.

17. Pace N, Strajman E, Walker E: Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 111:652, 1950.

18. Piantadosi CA: The role of hyperbaric oxygen in carbon monoxide, cyanide and sulfide intoxication. Prob Respir Care 4:215, 1991.

19. Piantadosi CA: Diagnosis and treatment of carbon monoxide poisoning. Respir Care Clin N Am 5:183, 1999.

20. Litovitz TL, Larkin RF, Myers RAM: Cyanide poisoning treated with hyperbaric oxygen. Am J Emerg Med 1:94, 1983.

21. Truss CD, Killenberg PG: Treatment of carbon tetrachloride with hyperbaric oxygen. Gastroenterology 82:767, 1982.

22. Berk RF, Lane JM, Patel K: Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion. J Clin Invest 74:1996, 1984.

23. Whitcraft DD, Bailey TD, Hart GB: Hydrogen sulfide poisoning treated with hyperbaric oxygen. J Emerg Med 3:23, 1985.

24. Smilkstein MJ, Bronstein AC, Pickett HM, Rumack BH: Hyperbaric oxygen therapy for severe hydrogen sulfide poisoning. J Emerg Med 3:27, 1985.

25. Bakker DJ, van der Kleij AJ: Soft tissue infections including clostridial myonecrosis: Diagnosis and treatment. In Oriani G, Marroni A, Wattel F (eds): Handbook on Hyperbaric Medicine. New York, Springer-Verlag, 1996, p 343.

26. Bakker DJ, van der Kleij AJ: Clostridial myonecrosis. In Oriani G, Marroni A, Wattel F (eds): Handbook on Hyperbaric Medicine. New York, Springer-Verlag, 1996, p 362.

2696

27. Demello FJ, Haglin JJ, Hitchcock CR: Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery and hyperbaric oxygen. Surgery 73:936, 1973.

28. Moon RE, Dear GdL, Stolp BW: Hyperbaric oxygen in critical care. In Ayres SM, Grenvik A, Holbrook PR, Shoemaker WC (eds): Textbook of Critical Care, 3rd ed. Philadelphia, WB Saunders, 1995, p 953.

29. Riseman JA, Zamboni WA, Curtis A, et al: Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for débridement. Surgery 108:847, 1990.

30. Zamboni WA, Kindwall EP: Author's reply to: Still unproved in necrotising fasciitis. BMJ 307:936, 1993.

31. Mader JT, Brown GL, Guckian JC, et al: A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142:915, 1980.

32. Davis JC, Heckman JD, DeLee JC, Buckwold FJ: Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg Am 68:1210, 1986.

33. Price JC, Stevens DL: Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90:737, 1980.

34. Yohai RA, Bullock JD, Aziz AA, Markert RJ: Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39:3, 1994.

35. Bouachour G, Cronier P, Gouello JP, et al: Hyperbaric oxygen therapy in the management of crush injuries: A randomized double-blind placebo-controlled clinical trial. J Trauma 41:333, 1996.

36. Zamboni WA, Roth AC, Russell RC, et al: The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg 5:343, 1989.

37. Zamboni WA, Roth AC, Russell RC, Smoot EC: The effect of hyperbaric oxygen on reperfusion of ischemic axial skin flaps: A laser Doppler analysis. Ann Plast Surg 28:339, 1992.

38. Nemiroff PM: Synergistic effects of pentoxifylline and hyperbaric oxygen on skin flaps. Arch Otolaryngol Head Neck Surg 114:977, 1988.

39. Zamboni WA, Wong HP, Stephenson LL: Effect of hyperbaric oxygen on neutrophil concentration and pulmonary sequestration in reperfusion injury. Arch Surg 131:756, 1996.

40. Hart GB, Mainous EG: The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer 37:2580, 1976.

41. Farmer JC Jr, Shelton DL, Angelillo JD, et al: Treatment of radiation-induced tissue injury by hyperbaric oxygen. Ann Otol Rhinol Laryngol 87:707, 1978.

42. Ferguson BJ, Hudson WR, Farmer JC Jr: Hyperbaric oxygen therapy for laryngeal radionecrosis. Ann Otol Rhinol Laryngol 96:1, 1987.

43. Norkool DM, Hampson NB, Gibbons RP, Weissman RM: Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol 150:332, 1993.

44. Bevers RF, Bakker DJ, Kurth KH: Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet 346:803, 1995.

45. Hammarlund C, Sundberg T: Hyperbaric oxygen reduced size of chronic leg ulcers: A randomized double-blind study. Plast Reconstr Surg 93:829, 1994.

46. Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA: Evaluation of hyperbaric oxygen for diabetic wounds—a prospective study. Undersea Hyperb Med 24:175, 1997.

47. Hart GB, Lennon PA, Strauss MD: Hyperbaric oxygen in exceptional acute blood-loss anemia. J Hyperbaric Med 2:205, 1987.

48. Camporesi EM, Moon RE: Hyperbaric oxygen as an adjunct to therapeutic lung lavage in pulmonary alveolar proteinosis. In Bove AA, Bachrach AJ, Greenbaum LJ Jr (eds): Underwater and Hyperbaric Physiology IX. Proceedings of the Ninth International Symposium on Underwater and Hyperbaric Physiology. Bethesda, MD, Undersea and Hyperbaric Medical Society, 1987, p 955.

49. Jansen HM, Zuurmond WW, Roos CM, et al: Whole-lung lavage under hyperbaric oxygen conditions for alveolar proteinosis with respiratory failure. Chest 91:829, 1987.

50. Hart GB, O'Reilly RR, Broussard ND, et al: Treatment of burns with hyperbaric oxygen. Surg Gynecol Obstet 139:693, 1974.

51. Niu AKC, Yang C, Lee HC, et al: Burns treated with adjunctive hyperbaric oxygen therapy—a comparative study in humans. J Hyperbaric Med 2:75, 1987.

52. Cianci P, Lueders HW, Lee H, et al: Adjunctive hyperbaric oxygen therapy reduces length of hospitalization in thermal burns. J Burn Care Rehabil 10:432, 1989.

53. Niezgoda JA, Cianci P, Folden BW, et al: The effect of hyperbaric oxygen therapy on a burn wound model in human volunteers. Plast Reconstr Surg 99:1620, 1997.

54. Broughton G 2nd: Management of the brown recluse spider bite to the glans penis. Mil Med 161:627, 1996.

55. Maynor ML, Moon RE, Klitzman B, et al: Brown recluse spider envenomation: A prospective trial of hyperbaric oxygen therapy. Acad Emerg Med 4:184, 1997.

56. Riley RL, Houston CS: Composition of alveolar air and volume of pulmonary ventilation during long exposure to high altitude. Am J Physiol 3:526, 1951.

57. West JB: Tolerable limits to hypoxia: On high mountains. In Sutton JR, Houston CS, Coates G (eds): Hypoxia. The Tolerable Limits. Indianapolis, IN, Benchmark Press, 1988, p 353.

58. West JB: Highest inhabitants in the world. Nature 324:517, 1986.

59. Rock PB, Johnson TS, Cymerman A, et al: Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4,300 m). Aviat Space Environ Med 58:668, 1987.

60. Forster PJG: Health and work at high altitude: A study at the Mauna Kea observatories. Publ Astronom Soc Pacific 96:478, 1984.

61. Scoggin CH, Hyers TM, Reeves JT, Grover RF: High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N Engl J Med 297:1269, 1977.

62. West JB: Acute mountain sickness at the South Pole? High Alt Med Biol 2:559, 2001.

63. West JB: Prediction of barometric pressures at high altitude with the use of model atmospheres. J Appl Physiol 81:1850, 1996.

64. Gilbert R, Keighley JF: The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am Rev Respir Dis 109:142, 1974.

65. Mathieu D, Neviere R, Pellerin P, et al: Pedicle musculocutaneous flap transplantation: Prediction of final outcome by transcutaneous oxygen measurements in hyperbaric oxygen. Plast Reconstr Surg 91:329, 1993.

66. Fife CE, Buyukcakir C, Otto GH, et al: The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: A retrospective analysis of 1,144 patients. Wound Repair Regen 10:198, 2002.

67. Demchenko IT, Boso AE, Natoli MJ, et al: Nitric oxide is involved in the mechanism of HBO-induced cerebral vasoconstriction. Undersea Hyperb Med 25(Suppl):54, 1998.

68. Demchenko IT, Oury TD, Crapo JD, Piantadosi CA: Regulation of the brain's vascular responses to oxygen. Circ Res 91:1031, 2002.

69. Stamler JS, Jia L, Eu JP, et al: Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276:2034, 1997.

70. McMahon TJ, Moon RE, Luschinger BP, et al: Nitric oxide in the human respiratory cycle. Nat Med 8:711, 2002.

71. Whalen R, Saltzman H, Holloway D, et al: Cardiovascular and blood gas responses to hyperbaric oxygenation. Am J Cardiol 15:638, 1965.

72. Park MK, Muhvich KH, Myers RAM, Marzella L: Effects of hyperbaric oxygen in infectious diseases: Basic mechanisms. In Kindwall EP (ed): Hyperbaric Medicine Practice. Flagstaff, AZ, Best Publishing, 1995, p 141.

73. Zamboni WA, Roth AC, Russell RC, et al: Morphological analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 91:1110, 1993.

2697

74. Zamboni WA, Stephenson LL, Roth AC, et al: Ischemia-reperfusion injury in skeletal muscle: CD 18-dependent neutrophil-endothelial adhesion and arteriolar vasoconstriction. Plast Reconstr Surg 99:2002, 1997.

75. Martin JD, Thom SR: Vascular leukocyte sequestration in decompression sickness and prophylactic hyperbaric oxygen therapy in rats. Aviat Space Environ Med 73:565, 2002.

76. Thom S: Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharmacol 105:340, 1990.

77. Bennett PB, Towse EJ: The high pressure nervous syndrome during a simulated oxygen-helium dive to 1500 ft. Electroencephalogr Clin Neurophysiol 31:383, 1971.

78. Bennett PB, Coggin R, Roby J: Control of HPNS in humans during rapid compression with trimix to 650 m (2132 ft). Undersea Biomed Res 8:85, 1981.

79. Winter PM, Smith RA, Smith M, Eger EI II: Pressure antagonism of barbiturate anesthesia. Anesthesiology 44:416, 1976.

80. Gran L, Coggin R, Bennett PB: Diazepam under hyperbaric conditions in rats. Acta Anaesthesiol Scand 24:407, 1980.

81. Tonner PH, Poppers DM, Miller KW: The general anesthetic potency of propofol and its dependence on hydrostatic pressure. Anesthesiology 77:926, 1992.

82. Tonner PH, Scholz J, Koch C, Schulte am Esch J: The anesthetic effect of dexmedetomidine does not adhere to the Meyer-Overton rule but is reversed by hydrostatic pressure. Anesth Analg 84:618, 1997.

83. Wardley-Smith B, Halsey MJ: Recent molecular theories of general anesthesia. Br J Anaesth 51:619, 1979.

84. Wann KT, Macdonald AG: Actions and interactions of high pressure and general anaesthetics. Prog Neurobiol 30:271, 1987.

85. Gross DR, Kramer WG, Gentile BJ, et al: Plasma volume and estimated liver plasma flow during hyperbaric and hyperoxic exposures in awake dogs. Aviat Space Environ Med 56:1203, 1985.

86. Kramer WG, Gross DR, Moreau PM, Fife WP: Drug disposition under hyperbaric and hyperbaric-hyperoxic conditions: Meperidine in the dog. Aviat Space Environ Med 54:410, 1983.

87. Kramer WG, Welch DW, Fife WP, et al: Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dog. Aviat Space Environ Med 54:1005, 1983.

88. Kramer WG, Gross DR, Fife WP, Chaikin BN: Theophylline pharmacokinetics during hyperbaria and hyperbaric hyperoxia in the dog. Res Commun Chem Pathol Pharmacol 34:381, 1981.

89. Kramer WG, Welch DW, Fife WP, et al: Salicylate pharmacokinetics in the dog at 6 ATA in air and at 2.8 ATA in 100% oxygen. Aviat Space Environ Med 54:682, 1983.

90. Stoudemire A, Miller J, Schmitt F, et al: Development of an organic affective syndrome during a hyperbaric diving experiment. Am J Psychiatry 141:1251, 1984.

91. Piantadosi CA, Lee PA, Sylvia AL: Direct effects of CO on cerebral energy metabolism in bloodless rats. J Appl Physiol 65:878, 1988.

92. Thom SR: Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning. J Appl Physiol 73:1584, 1992.

93. Thom SR: Functional inhibition of leukocyte β₂ integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 123:248, 1993.

94. Thom SR: Leukocytes in carbon monoxide-mediated brain oxidative injury. Toxicol Appl Pharmacol 123:234, 1993.

95. Thom SR, Fisher D, Manevich Y: Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. Am J Physiol Heart Circ Physiol 281:H923, 2001.

96. Norkool DM, Kirkpatrick JN: Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: A review of 115 cases. Ann Emerg Med 14:1168, 1985.

97. Shillito FH, Drinker CK, Shaughnessy TJ: The problem of nervous and mental sequelae in carbon monoxide poisoning. JAMA 106:669, 1936.

98. Scheinkestel CD, Jones K, Myles PS, et al: Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning—a randomized, controlled clinical trial. Med J Aust 170:203, 1999.

99. Ducassé JL, Celsis P, Marc-Vergnes JP: Non-comatose patients with acute carbon monoxide poisoning: Hyperbaric or normobaric oxygenation? Undersea Hyperb Med 22:9, 1995.

100. Mathieu D, Wattel F, Mathieu-Nolf M, et al: Randomized prospective study comparing the effect of HBO versus 12 hours NBO in non-comatose CO poisoned patients: Results of the interim analysis. Undersea Hyperb Med 23(Suppl):7, 1996.

101. Shepherd Ali G, Ashoka Ali A, Steinke JM, Shepherd AP: A simple method for measuring fetal hemoglobin by co-oximetry. Clin Chim Acta 307:249, 2001.

102. Pracyk JB, Stolp BW, Fife CE, et al: Brain computerized tomography after hyperbaric oxygen therapy for carbon monoxide poisoning. Undersea Hyperb Med 22:1, 1995.

103. Gale SD, Hopkins RO, Weaver LK, et al: MRI, quantitative MRI, SPECT, and neuropsychological findings following carbon monoxide poisoning. Brain Inj 13:229, 1999.

104. Parkinson RB, Hopkins RO, Cleavinger HB, et al: White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology 58:1525, 2002.

105. Hollander DI, Nagey DA, Welch R, Pupkin M: Hyperbaric oxygen therapy for the treatment of acute carbon monoxide poisoning in pregnancy. A case report. J Reprod Med 32:615, 1987.

106. Van Hoesen KB, Camporesi EM, Moon RE, et al: Should hyperbaric oxygen be used to treat the pregnant patient for acute carbon monoxide poisoning? A case report and literature review [published erratum appears in JAMA 1990;273:2750]. JAMA 261:1039, 1989.

107. Brown DB, Mueller GL, Golich FC: Hyperbaric oxygen treatment for carbon monoxide poisoning in pregnancy: A case report. Aviat Space Environ Med 63:1011, 1992.

108. Elkharrat D, Raphael JC, Korach JM, et al: Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy. Intensive Care Med 17:289, 1991.

109. Mathieu D, Wattel F, Nevière R, Mathieu-Nolf M: Carbon monoxide poisoning: Mechanism, clinical presentation and management. In Oriani G, Marroni A, Wattel F (eds): Handbook on Hyperbaric Medicine. New York, Springer-Verlag, 1996, p 281.

110. Camporesi EM: Hyperbaric oxygen therapy for CO intoxication during pregnancy. In Oriani G, Marroni A, Wattel F (eds): Handbook on Hyperbaric Medicine. New York, Springer-Verlag, 1996, p 305.

111. Kaufman BS, Kaminsky SJ, Rackow EC, Weil MH: Adult respiratory distress syndrome following orogenital sex during pregnancy. Crit Care Med 15:703, 1987.

112. Morris WP, Butler BD, Tonnesen AS, Allen SJ: Continuous venous air embolism in patients receiving positive end-expiratory pressure. Am Rev Respir Dis 147:1034, 1993.

113. Moon RE, Camporesi EM, Kisslo JA: Patent foramen ovale and decompression sickness in divers. Lancet 1:513, 1989.

114. Wilmshurst PT, Byrne JC, Webb-Peploe MM: Relation between interatrial shunts and decompression sickness in divers. Lancet 2:1302, 1989.

115. Germonpré P, Dendale P, Unger P, Balestra C: Patent foramen ovale and decompression sickness in sports divers. J Appl Physiol 84:1622, 1998.

116. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648, 2000.

117. Wilmshurst PT, Pearson MJ, Walsh KP, et al: Relationship between right-to-left shunts and cutaneous decompression illness. Clin Sci (Lond) 100:539, 2001.

118. Cantais E, Louge P, Suppini A, et al: Right-to-left shunt and risk of decompression illness with cochleovestibular and cerebral symptoms in divers: Case control study in 101 consecutive dive accidents. Crit Care Med 31:84, 2003.

2698

119. Brunner F, Frick P, Bühlmann A: Post-decompression shock due to extravasation of plasma. Lancet 1:1071, 1964.

120. Boussuges A, Blanc P, Molenat F, et al: Haemoconcentration in neurological decompression illness. Int J Sports Med 17:351, 1996.

121. Helps SC, Parsons DW, Reilly PL, Gorman DF: The effect of gas emboli on rabbit cerebral blood flow. Stroke 21:94, 1990.

122. Helps SC, Meyer-Witting M, Rilley PL, Gorman DF: Increasing doses of intracarotid air and cerebral blood flow in rabbits. Stroke 21:1340, 1990.

123. Helps SC, Gorman DF: Air embolism of the brain in rabbits pre-treated with mechlorethamine. Stroke 22:351, 1991.

124. Pearson RR, Goad RF: Delayed cerebral edema complicating cerebral arterial gas embolism: Case histories. Undersea Biomed Res 9:283, 1982.

125. Elliott DH, Moon RE: Manifestations of the decompression disorders. In Bennett PB, Elliott DH (eds): The Physiology and Medicine of Diving. Philadelphia, WB Saunders, 1993, p 481.

126. Divers Alert Network: Report on Decompression Illness, Diving Fatalities and Project Dive Exploration. Durham, NC, Divers Alert Network, 2004.

127. Moon RE: Adjunctive Therapy for Decompression Illness. Kensington, MD, Undersea and Hyperbaric Medical Society, 2003.

128. Merton DA, Fife WP, Gross DR: An evaluation of plasma volume expanders in the treatment of decompression sickness. Aviat Space Environ Med 54:218, 1983.

129. Ziser A, Adir Y, Lavon H, Shupak A: Hyperbaric oxygen therapy for massive arterial air embolism during cardiac operations. J Thorac Cardiovasc Surg 117:818, 1999.

130. Wherrett CG, Mehran RJ, Beaulieu MA: Cerebral arterial gas embolism following diagnostic bronchoscopy: Delayed treatment with hyperbaric oxygen. Can J Anaesth 49:96, 2002.

131. Benson J, Adkinson C, Collier R: Hyperbaric oxygen therapy of iatrogenic cerebral arterial gas embolism. Undersea Hyperb Med 30:117, 2003.

132. Moon RE, Gorman DF: Treatment of the decompression disorders. In Neuman TS, Brubakk AO (eds): The Physiology and Medicine of Diving. New York, Elsevier, 2003, p 600.

133. Moon RE: Treatment of decompression sickness and arterial gas embolism. In Bove AA (ed): Diving Medicine. Philadelphia, WB Saunders, 2004, p 195.

134. Dexter F, Hindman BJ: Recommendations for hyperbaric oxygen therapy of cerebral air embolism based on a mathematical model of bubble absorption. Anesth Analg 84:1203, 1997.

135. Van Unnik AJM: Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie van Leeuwenhoek 31:181, 1965.

136. Clarke LA, Moon RE: Hyperbaric oxygen in the treatment of life threatening soft tissue infections. Respir Care Clin N Am 5:203, 1999.

137. Allen DB, Maguire JJ, Mahdavian M, et al: Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 132:991, 1997.

138. Greif R, Akca O, Horn EP, et al: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 342:161, 2000.

139. Luongo C, Imperatore F, Cuzzocrea S, et al: Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 26:1972, 1998.

140. Cuzzocrea S, Imperatore F, Costantino G, et al: Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock 13:197, 2000.

141. Rachmilewitz D, Karmeli F, et al: Hyperbaric oxygen: A novel modality to ameliorate experimental colitis. Gut 43:512, 1998.

142. Smith RM: Anesthesia during hyperbarix oxygenation. Ann N Y Acad Sci 117:768, 1965.

143. Li W, Zhang Z, Liao C, Xie W: Open heart surgery with extracorporeal circulation under hyperbaric oxygenation at 3 ATA. In Kindwall EP (ed): Proceedings of the Eighth International Congress on Hyperbaric Medicine. San Pedro, CA, Best Publishing, 1987, p 177.

144. Navy Department: US Navy Diving Manual, Revision 3, vol 1: Air Diving. NAVSEA 0994-LP-001-9110. Flagstaff, AZ, Best Publishing, 1993.

145. Weaver LK, Strauss MB: Monoplace Hyperbaric Chamber Safety Guidelines. Kensington, MD, Undersea and Hyperbaric Medical Society, 1997.

146. Weaver LK: Operational use and patient care in the monoplace hyperbaric chamber. Respir Care Clin N Am 5:51, 1999.

147. Miller JN, Fagraeus L, Bennett PB, et al: Nitrogen-oxygen saturation therapy in serious cases of compressed air decompression sickness. Lancet 2:169, 1978.

148. Davis P, Piantadosi CA, Moon RE: Saturation treatment of decompression illness in a hospital based hyperbaric facility. In Moon RE, Sheffield PJ (eds): Treatment of Decompression Illness. Kensington, MD, Undersea and Hyperbaric Medical Society, 1996, p 294.

149. Yusa T, Beckman JS, Crapo JD, Freeman BA: Hyperoxia increases H₂ O₂ production by brain in vivo. J Appl Physiol 63:353, 1987.

150. Clark JM, Lambertsen CJ: Rate of development of pulmonary oxygen toxicity in man during oxygen breathing at 2.0 ATA. J Appl Physiol 30:739, 1971.